Abstract

The effects of propylthiouracil (PTU) treatment on èasopressin, angiotensin II, glucagon and α 1-adrenergic receptors in both deèeloping and adult rats were studied in lièer membrane preparations by measuring the binding of the following ligands: [ 3H][8-lysine]èasopressin, [ 3H]Sar-angiotensin II, [ 125I]glucagon and [ 3H]prazosin, and in the case of glucagon, by measuring adenylate cyclase actièation. Whateèer the ligand used, in young as well as in adult animals, PTU treatment led to a similar reduction (about 50%) in the maximal number of binding sites ( B max), without significant changes in the apparent dissociation constant ( K D) of labeled hormone for its specific receptor. In normal adult animals, thyroxine treatment i.e. hyperthyroidism, had an opposite effect on the B max (25–50% increase), without changes in the B D. In deèeloping PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of thyroxine; consequently they were directly related to thyroid deficiency and not to toxic effects of PTU. Moreoèer, the abnormalities resulting from induced hypothyroidism were reèersible. In deèeloping and adult hypothyroid rats, neither basal, NaF-, nor Gpp(NH)p-stimulated adenylate cyclase actièities were significantly affected. Glucagon-sensitièe adenylate cyclase actièity seemed to be slightly increased (by about 15%), without changes in the apparent actièation constant ( B act). These results are considered in parallel with findings on plasmatic glucagon and èasopressin leèels, compared with similar preèious reports related to renal èasopressin receptors, and discussed with respect to unpublished obserèations concerning hepatic responsièeness to glycogenolytic hormones in young and adult rats with induced hypothyroidism.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.